NIH-funded research R01 grant

Investigating how a specific gene affects smooth muscle cells in heart disease.

Official title: The role of Twist1 in SMC phenotypic modulation during atherosclerosis

Funded at Univ of North Carolina Chapel Hill · NIH-10989901 · Data updated 2026-11-12

This study is looking at how a gene called Twist1 affects smooth muscle cells in your arteries as they change during atherosclerosis, which can lead to heart disease, to find new ways to help keep your heart healthy.

More Atherosclerosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startDecember 1, 2023
Project endNovember 30, 2028
Funding year2025
Award (this year)$465,968
NIH project number5R01HL171275-02
Project IDNIH-10989901 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for atherosclerosis or those with existing cardiovascular conditions.

Less likely to help

Patients without cardiovascular risk factors or those with non-atherosclerotic conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of a gene called Twist1 in the behavior of smooth muscle cells (SMCs) during the development of atherosclerosis, a condition that can lead to heart disease. By using advanced techniques like single cell RNA sequencing, the researchers aim to observe how SMCs change their characteristics and contribute to the formation of arterial plaques. The study will explore how these changes can influence disease progression and risk factors associated with coronary artery disease. Ultimately, the goal is to identify potential therapeutic targets that could improve heart health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that reduce the risk of heart disease by targeting specific cellular processes.

How similar studies have gone: Previous research has shown promising results in understanding the genetic factors influencing atherosclerosis, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Wirka, Robert — Univ of North Carolina Chapel Hill
  • Study coordinator: Wirka, Robert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.